Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease

NCT03533257 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: AMX0035
DRUG: Placebo

Sponsor

Amylyx Pharmaceuticals Inc.

Collaborators

[object Object]
[object Object]